AbbVie Inc. (ABBV) Free cash flow 2016–2025
AbbVie Inc. (ABBV) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$17.8BFY2025 · since FY2016: $6.6B → $17.8B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $17.8B | -0.1% |
| FY2024 | $17.8B | -19.2% |
| FY2023 | $22.1B | -9.0% |
| FY2022 | $24.2B | +10.3% |
| FY2021 | $22.0B | +31.0% |
| FY2020 | $16.8B | +31.5% |
| FY2019 | $12.8B | -0.1% |
| FY2018 | $12.8B | +35.6% |
| FY2017 | $9.4B | +43.7% |
| FY2016 | $6.6B | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice